Company Overview and News


Add 531349
to your dashboard

Headline News

Glenmark#39;s Glenn Saldanha takes over as president of pharma lobby group IPA

12h moneycontrol
Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals has taken over as the President of domestic pharmaceutical lobby group Indian Pharmaceutical Alliance (IPA).

Panacea Biotec, MSF India oppose Pfizer’s pneumonia vaccine patent

2017-10-13 livemint
New Delhi: The grant of a patent to Pfizer Inc.’s pneumonia vaccine Prevenar 13 has been opposed by Indian vaccine maker Panacea Biotec Ltd and MSF (Médecins Sans Frontières) India, the local unit of Paris-based humanitarian aid organization. (16-0)

Panacea Biotec Limited - Shareholders meeting

2017-09-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Shareholders meeting

2017-09-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Shareholders meeting

2017-09-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Updates

2017-09-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Panacea Biotec Limited - Reply to Clarification Sought

2017-09-15 feedproxy.google
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Panacea Biotec to demerge realty business into separate listed company; stock up 10%

2017-09-14 moneycontrol
Panacea Biotec share price surged 10 percent intraday Thursday as the company is going to demerge its realty business into a separate listed company.

Panacea Biotec Limited - Updates

2017-09-14 feedproxy.google
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Panacea Biotec Limited - Clarification

2017-09-14 feedproxy.google
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Panacea Biotec Limited - Financial Result Updates

2017-09-13 feedproxy.google
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

Don#39;t expect unusual risks in development of drugs: Panacea Biotech

2017-08-01 moneycontrol
Panacea Biotec has entered into a joint collaboration with Bion Pharma. In an interview to CNBC-TV18, Rajesh Jain, Joint MD of Panacea Biotech spoke about the latest happenings in his company and sector.

Panacea Biotec, US#39;s Bionpharma join hands for 7 drugs

2017-07-28 moneycontrol
Drug firm Panacea Biotec today said it has entered into a joint collaboration with the US's Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products.

Panacea Biotec, US’ Bionpharma join hands for manufacture of 7 drugs

2017-07-28 thehindubusinessline
Drug firm Panacea Biotec today said it has entered into a joint collaboration with the US’s Bionpharma for development, licence, manufacturing, supply and sales of seven complex generic products.

Panacea Biotec Limited - Press Release

2017-07-28 feedproxy.google

Bioengineered Protein Drugs Market Worth US$336.9 Billion by 2025: Increasing Drugs in Phase III of Clinical Trials to Boost the Market

2017-07-25 prnewswire
Some of the prominent participants in the global bioengineered protein drugs market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Amgen, Inc., Bayer AG, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Eli Lilly and Company, Sanofi, Fresenius Kabi, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Panacea Biotec, ProBioGen AG, and Reliance Life Sciences Pvt. Ltd.

Panacea Biotec Limited - Results

2017-05-16 feedproxy.google

The worldwide paediatric vaccine market is projected to be valued at US$ 88.14 Bn by the end of 2026.

2017-05-02 prnewswire
LONDON, May 2, 2017 /PRNewswire/ -- Global Paediatric Vaccine Market: Towards a better and safer tomorrow Paediatric vaccines are administered to a child in its paediatric age which is from 0 – 18 years of age. Vaccines are generally given in order to prevent children from diseases transferred through infections, seasonal variations and even through unhygienic areas. Depending upon disease, the vaccines are administered at regular intervals.

Narayana Hrudayalaya to buy Panacea Biotec’s NewRise Healthcare for Rs180 crore

2017-04-21 livemint
The company has entered an agreement to acquire 100% stake in NewRise Healthcare from Panacea Biotec, Narayana Hrudayalaya said in a BSE filing

FACTBOX: Investors weigh risks of Le Pen victory in imminent French elections

2017-04-21 in.reuters
LONDON The markets are gearing up for the first round of the French presidential election on Sunday, with opinion polls indicating far-right candidate Marine Le Pen and centrist Emmanuel Macron have lost momentum in the last few days.

Narayana Hrudayalaya inks pact with Panacea Biotec

2017-04-21 thehindubusinessline
Narayana Hrudayalaya has entered into an agreement with Panacea Biotec to fully acquire its subsidiary NewRise Healthcare for an enterprise value of Rs 180 crore.

Panacea Biotec up 9%, to sell 100% stake in arm to Narayana Hrudayalaya

2017-04-21 moneycontrol
Shares of Panacea Biotec rose 9.6 percent intraday Friday as it is going to sell its entire stake in NewRise Healthcare to Narayana Hrudayalaya.

Narayana Hrudayalaya to buy NewRise Healthcare

2017-04-21 moneycontrol
Healthcare services provider Narayana Hrudayalaya Ltd said it would buy NewRise Healthcare Private Ltd from Panacea Biotec Ltd for an enterprise value of 1.80 billion rupees ($27.87 million).

BPCL seeks diesel cargoes as refinery maintenance extended - sources

2017-04-21 in.reuters
SINGAPORE Bharat Petroleum Corp Ltd (BPCL) (BPCL.NS) is seeking diesel cargoes in a rare move as a planned maintenance shutdown at its Mumbai refinery takes longer than expected to complete, trading and refining sources said.